Skip to main content
GutCited

Bifidobacterium lactis के लिए Chronic Constipation

B

Dose-dependently reduces whole gut transit time (WGTT). Higher dose (17.2 billion CFU) showed 31% reduction in WGTT. Also reduces functional GI symptoms.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dlactis\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Dose-dependently reduces whole gut transit time (WGTT). Higher dose (17.2 billion CFU) showed 31% reduction in WGTT. Also reduces functional GI symptoms.

Key Study Findings

Randomized Controlled Trial 8 weeks Double-blind
Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, …
Dose: None बनाम: Placebo Outcome: Complete spontaneous bowel movements (CSBMs) प्रभाव: None None

जनसंख्या: Adults with functional constipation (Rome III)

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None बनाम: Placebo Outcome: Weekly spontaneous bowel movements प्रभाव: 4.94 vs 3.00 (P<0.001) P<0.001

जनसंख्या: Older adults >=60 with functional constipation (Rome IV)

Randomized Controlled Trial n=35 12 weeks Double-blind
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable …
Dose: None बनाम: Placebo Outcome: Gut barrier function (zonulin levels) प्रभाव: Zonulin -19.5 ng/mL at week 16 p=0.0002 wk16; p=0.0053 grp

जनसंख्या: IBS without constipation patients

Review
An update on probiotics in paediatrics.
Dose: None बनाम: None Outcome: GI disorder outcomes in paediatrics प्रभाव: None None

जनसंख्या: Paediatric patients with GI disorders

In Vitro n=35
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum …
Dose: 1e6 CFU/mL बनाम: IBS supernatants without probiotic Outcome: Caco-2 paracellular permeability प्रभाव: None <0.001

जनसंख्या: IBS patients (28) and asymptomatic controls (7)

Randomized Controlled Trial n=128 2 weeks Double-blind
Probiotics and Fever Duration in Children With Upper Respiratory Tract Infections: A Randomized Clinical Trial.
Dose: 0.5 mL daily for 14 days बनाम: Placebo Outcome: Fever duration (days) प्रभाव: RR 0.64 (95% CI 0.51-0.80) None

जनसंख्या: Children 28 days-4 years with fever and URTI

Key Statistics

4

अध्ययन

600

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

Current opinion in … 2025
Clinical nutrition (Edinburgh, … 2020 94 उद्धरण
Pediatric gastroenterology, hepatology … 2017 27 उद्धरण
World journal of … 2010 276 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
1-10 billion CFU/day
immunesupport:
5-10 billion CFU/day
constipationsupport:
17.2 billion CFU/day (HN019 strain, optimal dose)

अधिकतम सीमा: Well-tolerated up to 17.2 billion CFU/day in clinical trials

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None 8 weeks Neutral --
None 4 weeks Positive 67
None 12 weeks Positive 35
None -- Positive --
1e6 CFU/mL -- Positive 35
0.5 mL daily for 14 days 2 weeks Positive 128
None 2 weeks Negative 117
10 g 4 weeks Positive --

सेवन का सर्वोत्तम समय: With or without food; morning dosing may be optimal for transit effects

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Mild gas and bloating during initial use
  • Occasional abdominal discomfort
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

ज्ञात अंतःक्रियाएँ

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (use with caution in immunocompromised patients)

सहनीय अधिकतम सेवन: Well-tolerated up to 17.2 billion CFU/day in clinical trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Bifidobacterium lactis help with Chronic Constipation?
Based on 4 studies with 600 participants, there is moderate evidence from clinical studies that Bifidobacterium lactis may support Chronic Constipation management. Our evidence grade is B (Good Evidence).
How much Bifidobacterium lactis should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bifidobacterium lactis?
Reported side effects may include Mild gas and bloating during initial use, Occasional abdominal discomfort, Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bifidobacterium lactis and Chronic Constipation?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Chronic Constipation

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।